Primary mediastinal large B-cell lymphoma: The need for prospective controlled clinical trials

Leukemia and Lymphoma

Volumn 35, Issue 5-6, 1999, Pages 537-544

  Bieri, Sabine ^a,c   Roggero, Enrico ^a   Zucca, Emanuele ^a   Bertoni, Francesco ^a   Pianca, Silvio ^a   Sanna, Piero ^a   Pedrinis, Ennio ^b   Bernier, Jacques ^a   Cavalli, Franco ^a  

^a SAN GIOVANNI HOSPITAL   (Switzerland)

^b INSTITUTE OF PATHOLOGY   (Switzerland)

^c Serv Cantonale Radioterapia Osp S   (Switzerland)

Author keywords

Chemotherapy; Outcome; Primary mediastinal large B cell lymphoma; Radiation therapy

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; PREDNISOLONE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; DOSIMETRY; FEMALE; HIGH RISK PATIENT; HUMAN; LARGE CELL LYMPHOMA; MALE; MEDIASTINUM TUMOR; PRIORITY JOURNAL; PROGNOSIS; REMISSION; STATISTICAL ANALYSIS; SYMPTOM; TREATMENT OUTCOME;

EID: 0033390987     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428199909169618     Document Type: Article

References (29)

1. Harris, N. L., Jaffe, E. S., Stein, H., Banks, P. M., Chean, J. K. C., Cleary, M. L., et al. (1994). A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood, 84, 1361-1392.
2. The Non-Hodgkin's Lymphoma Classification Project. (1997). A clinical evaluation of the International Lymphoma Study Group Classification of the Non-Hodgkin's Lymphoma. Blood: 89, 3909-3918.
3. Anderson, J. R., Armitage, J. O., Weisenburger, D. D. (1998). Epidemiology of the non-Hodgkin's lymphomas: Distribution of the major subtypes differ by geographic location. Ann Oncol. 9, 717-720.
4. Addis, B. J., Isaacson, P. G. (1986). Large cell lymphoma of the mediastinum: a B-cell tumor of probable thymic origin. Histopathology, 10, 379-390.
5. Menestrina, F., Chilosi, M., Bonetti, F., et al. (1986). Mediastinal large cell lymphoma of the B type, with sclerosis: histopathologic and immuno-histochemical study of eight cases. Histopathology, 10, 589-600.
6. Möller, P., Lammler, B., Eberlein-Gonska, M., et al. (1986). Primary mediastinal clear cell lymphoma of B-cell type. Virchow Arch (Pathol Anat). 412, 79-92.
7. Scarpa, A., Bonetti, F. Menestrina, F., et al. (1987). Mediastinal large-cell lymphoma with sclerosis. Genotypic analysis established its B nature. Virchows, Arch: 412, 17-21.
8. Lamarre, L., Jacobson, J. O., Aisenberg, A. C., Harris, N. L. (1989). Primary large cell lymphoma of the mediastinum: A histologic and immunophenotypic study of 29 cases. Am J Surg Pathol, 13, 730-739.
9. Lazzarino, M., Orlandi, E., Paulli, M., Boveri, E., Morra, A., Brusamolino, E., Gianelli, U., Gargantini, L. et al. (1993). Primary mediastinal B-cell lymphoma with sclerosis: An aggressive tumor with distinct clinical and pathologic features. J Clin Oncol: 11, 2306-2316.
10. Rohatiner, A. Z. S., Whelan, J. S., Ganjoo, R. K., Norton, A. J., Wilson, A., Lister, T. A. (1994). Mediastinal large-cell lymphoma with sclerosis (MLCLS). Br. J Cancer, 69, 601-604.
11. Lazzarino, M., Orlandi, E., Paulli, M., Sträter, J., Klersy, C., Gianelli, U., Gargantini, L., et al. (1997). Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients. J Clin Oncol, 15, 1646-1653.
12. Aisenherg, A. (1993). Primary large-cell ymphoma of the mediastinum. J Clin Oncol, 12, 2291-2294.
13. Miller, J. B., Variakojis, D., Bitran, J. D., Sweet, D., et al. (1981). Diffuse histiocytic lymphoma with sclerosis: a clinicopathologic entity frequently causing superior vena caval obstruction. Cancer, 47, 748-756.
14. Levitt, L., Aisenberg, A., Harris, N., Linggood, R., Poppema, S. (1982). Primary non-Hodgkin's lymphoma of the mediastinum. Cancer, 50, 2486-2492.
15. Shaffer, K., Smith, D., Kirn, D., et al. (1996). Primary mediastinal large B-cell lymphoma: radiologie findings at presentation. Am. J Roentgenol, 167, 425-430.
16. Trump, D. L., Mann, R. B. (1982). Diffuse large cell and undifferentiated lymphomas with prominent mediastinal involvement. A poor prognostis subset of patients with non-Hodgkin's lymphoma. Cancer, 50, 277-282.
17. Bertini, M., Orsucci, L., Vitolo, U., Levis, A., Tosdeschini, G., Meneghini, V., et al. (1991). Stage II large B-cell lymphoma with sclerosis treated with MACOP-B. Ann Oncol, 2, 733-737.
18. Jacobson, J. O., Aisenberg, A. C., Lamarre, L., Willett, C. G., Linggood, R. M., Miketic, L. M., Harris, N. L. (1988). Mediastinal large cell lymphoma. An uncommon subset of adult lymphoma curable with combined modality. Cancer: 62, 1893-1898.
19. Kim, D., Mauch, P., Shaffer, K., Pinkus, G., Shipp, M. A., Kaplan, W. D., Tung, N., Wheeler, C., Beard, C. J., Canellos, G. P. and L. N. Shulman. (1993). Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients. J Clin Oncol, 11, 1336-1343.
20. Zinzani, P. L., Bendandi, M., Frezza, G., et al. (1996). Primary mediastinal B-cell lymphoma with sclerosis: clinical and therapeutic evaluation of 22 patients. Leuk Lymphoma, 21, 311-316.
21. Todeschini, G., Ambrosetti, A., Meneghini, V. (1990). Mediastinal large B-cell lymphoma with sclerosis: a clinical study of 21 patients. J Clin Oncol, 8, 804-808.
22. Martelli, M. P., Martelli, M., Pescarmona, E., De Sanctis, V., Donalo, V., Palombi, F. Todisco, E., Rendina, E. A., Mandelli, F. (1998 in press). MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis. Ann Oncol.
23. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. (1993). A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med, 329, 987-944.
24. Zucca, E., Martinelli, G., Csontos, S., Cavalli, F. (1993). MACOP/CytaBEP: a novel effective treatment for aggressive non Hodgkin's lymphomas. Proc Am Soc Clin Oncol (abstract), 12, 369.
25. Miller, A. B. (1981). Recommendations for grading of acute and subacute toxicity (WHO criteria). Cancer, 47, 207.
26. Cazals-Hatem, D., Lepage, E., Brice, P., et al. (1996). Primary mediastinal large B-cell lymphomas, a GELA (Groupe d'Etude des Lymphomes de l'Adulte) study. Am. J. Surg Pathol. 20, 877-888.
27. Fisher, R. I., Gaynor, E. R., Dahlherg, G., et al. (1993). Comparison of standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl. J Med. 328, 1002-1006.
28. Sehn, L. H., Antin, J. H., Shulman, L. N., Mauch, P., Elias, A., Kadin, M. E., and Wheeler, C. (1998). Primary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation. Blood, 91, 717-723.
29. Popat, U., Przepiork, D., Champlin, R., Pugh, W., Amin, K., Mehra R., et al. (1998). High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome. J Clin Oncol, 16, 63-69.